查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085740

心臟移植市場：2026-2032年全球市場預測（依移植類型、移植物保存方法、產品、病患年齡層、最終用戶和適應症分類）

Heart Transplant Market by Transplant Type, Graft Preservation, Product, Patient Age Group, End User, Indication - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟移植市場將成長至 288.5 億美元，複合年成長率為 10.41%。

主要市場統計數據
基準年 2025 144.1億美元
預計年份：2026年 158.6億美元
預測年份 2032 288.5億美元
複合年成長率 (%) 10.41%

對於某些末期心臟衰竭患者，當基於指南的藥物治療、器械治療和長期機械循環支持無法提供足夠的生存率或生活品質改善時，心臟移植仍然是最終的治療選擇。由於人口老化、糖尿病、高血壓、缺血性心臟疾病和先天性心臟疾病存活率的提高，心肌病，導致心臟衰竭盛行率上升，心臟移植的需求量居高不下。

心臟移植生態系統受到供體器官供應、移植中心容量、免疫相容性、手術全期風險、終身免疫抑制治療需求等因素的限制。來自器官移植網路/器官移植註冊中心 (OPTN/SRTR) 和國際心肺移植協會 (ISHLT) 的檢驗註冊數據顯示，儘管在高容量市場，每年的移植數量正在增加，但緊張的等待名單、供體器官轉移以及區域間移植機會不均等問題仍然是臨床和商業性面臨的挑戰。

心臟移植領域的變革性變化

目前的情況正從應對器官短缺的模式轉向技術驅動的器官利用模式。隨著循環停止後器官捐贈、體外機械灌注、供體評估的改進以及物流的最佳化，移植項目現在能夠評估那些原本可能被浪費的供體心臟，尤其是在器官獲取網路完善、擁有專業心臟團隊的成熟市場。

人工智慧（AI）的累積影響

人工智慧 (AI) 正從單一產品類型發展成為貫穿整個心臟移植流程的累積能力。 AI 驅動的分析有助於候選人風險分層、供體-受體匹配、影像分析、血流動力學趨勢分析、供體心臟相容性評估，甚至能夠從電子健康記錄、實驗室數據、穿戴式裝置、切片檢查和分子診斷結果中早期發現排斥反應和感染疾病的徵兆。

主要區域趨勢

在亞太地區，由於對三級醫療投入的增加、心臟衰竭患者數量的成長以及中國、印度、日本、韓國和澳大利亞等國移植項目的擴展，市場正在擴張；然而，遺體捐贈者的數量、公眾意識、分配管治以及報銷制度的一致性等方面存在相當大的差異。以美國和加拿大為首的北美地區仍然是移植能力最強的地區，這得益於成熟的器官捐贈網路、先進的機械循環支持設備、完善的移植中心認證體係以及通過國家登記系統進行的健全的治療結果報告。

對關鍵群體的洞察

東協市場的特點是心血管疾病負擔日益加重，三級醫療機構不斷發展，但心臟移植能力仍集中在醫療體系較先進的地區，這些地區擁有完善的腦死捐贈者計畫、移植管治和術後重症監護設施。在海灣合作理事會（GCC）國家，受醫療轉型策略和對複雜心血管疾病治療日益成長的需求的推動，對心臟中心、移植法規、國家捐贈者登記系統和先進心臟衰竭治療服務的投資正在加速成長。

主要國家的概況

根據器官移植網路（OPTN）的數據，美國每年心臟移植手術數量位居全球之首，預計2023年將進行超過4,500例心臟移植手術。這得歸功於其覆蓋全國的器官分配系統、完善的器官獲取機構、廣泛使用的機械循環支持裝置以及詳盡的手術結果報告。加拿大透過區域性移植計畫、公共醫療保險和協調的捐贈者系統，保持良好的移植效果。另一方面，墨西哥和巴西在拉丁美洲的醫療保健服務中發揮著至關重要的作用，儘管兩國在醫療保健服務取得、捐贈者資源和專業醫療機構分佈方面存在區域差異。

為行業領導者提供的實用建議

行業領導者應優先考慮器官的高效利用、治療結果的透明度和移植後綜合護理。投資體外灌注、供體心臟評估、快速物流、分子層面排斥反應監測、感染疾病控制、免疫抑制療法的最佳化、藥物依從性支持和遠端監測，可以直接解決捐贈者短缺和移植器官長期保存的根本挑戰。

調查方法

本執行摘要基於二手研究，資料來源包括檢驗的公共和機構資源，例如移植登記處、同行評審的臨床文獻、衛生署出版刊物、器官捐贈組織、國際移植學會和監管機構。主要參考框架包括器官移植網路/器官移植註冊中心（OPTN/SRTR）、國際心肺移植協會（ISHLT）登記報告、歐洲移植協會（Eurotransplant）和各國移植機構數據、世界衛生組織（WHO）醫療衛生系統指標以及已發表的心臟衰竭流行病學數據。

結論

心臟移植領域正透過臨床創新、器官保存技術、數位化決策支援以及移植系統管治水準的提升而不斷進步。然而，核心挑戰依然存在：合適的捐贈心臟需求遠超供應，因此，器官識別、保存、分配、移植以及移植後管理的每項改進都至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心臟移植市場：依移植類型分類

  • 異位移植
  • 原位移植
    • 雙心房移植
    • 拜卡巴爾法
  • 心肺移植

第8章：心臟移植市場：依移植保存方法分類

  • 機械灌注
    • 低溫灌注
    • 正常體溫灌注
  • 靜態冷藏

第9章 心臟移植市場：依產品分類

  • 供體來源移植
    • 腦死後器官捐贈（DBD）
    • 循環停止後器官捐贈（DCD）
  • 機械循環輔助
    • 左心室輔助裝置（LVAD）
    • 右心室輔助裝置（RVAD）
    • 雙心室輔助裝置（BiVAD）
  • 人工心臟
  • 器官保存運輸系統

第10章 心臟移植市場：依病患年齡層別分類

  • 成人
  • 老年人
  • 兒童

第11章：心臟移植市場：依最終用戶分類

  • 醫院
  • 移植中心
  • 專業心臟病中心

第12章：心臟移植市場：依適應症分類

  • 先天性心臟疾病
  • 擴大性心肌病
  • 末期心臟衰竭
  • 缺血性心肌病變
  • 心臟瓣膜疾病

第13章 心臟移植市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 心臟移植市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 心臟移植市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Berlin Heart GmbH
  • BiVACOR, Inc.
  • Boston Scientific Corporation
  • Braile Biomedica Industria Comercio E Representacoes Ltda.
  • BrioHealth Solutions, Inc.
  • CARMAT SAS
  • CH Biomedical, Inc.
  • EUROSETS SRL
  • FineHeart
  • Fresenius Medical Care AG
  • Getinge AB
  • Hemovent GmbH
  • Jarvik Heart, Inc.
  • Johnson & Johnson
  • LivaNova PLC
  • magAssist Co., Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • ReliantHeart, Inc.
  • SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
  • Shenzhen Core Medical Technology Co., Ltd.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Terumo Corporation
Product Code: MRR-437E9896A565

The Heart Transplant Market is projected to grow by USD 28.85 billion at a CAGR of 10.41% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.41 billion
Estimated Year [2026] USD 15.86 billion
Forecast Year [2032] USD 28.85 billion
CAGR (%) 10.41%

Heart transplantation remains the definitive therapy for selected patients with end-stage heart failure when guideline-directed medical therapy, device therapy, and durable mechanical circulatory support no longer provide adequate survival or quality-of-life benefit. Demand is structurally high as heart failure prevalence rises with population aging, diabetes, hypertension, ischemic heart disease, congenital heart disease survival, and improved cardiomyopathy diagnosis rates.

The heart transplant ecosystem is constrained by donor-organ availability, transplant-center capacity, immunologic matching, perioperative risk, and lifelong immunosuppression needs. Verified registry evidence from OPTN/SRTR and the International Society for Heart and Lung Transplantation shows that annual transplant activity has increased in high-capacity markets, while waitlist pressure, donor conversion, and regional access gaps remain defining clinical and commercial challenges.

Transformative Shifts in the Heart Transplant Landscape

The landscape is shifting from a scarcity-managed model toward a technology-enabled organ utilization model. Donation after circulatory death, normothermic machine perfusion, improved donor assessment, and better logistics are enabling transplant programs to evaluate donor hearts that previously may not have been used, particularly in mature markets with strong procurement networks and specialized cardiac teams.

Policy and payment changes are also reshaping competition. Allocation frameworks increasingly prioritize urgency, broader sharing, measurable outcomes, and equitable access, while hospitals face growing scrutiny on survival, readmissions, infection control, rejection surveillance, and cost efficiency. These shifts favor transplant centers and suppliers that combine clinical excellence with data infrastructure, rapid transport coordination, and post-transplant monitoring capabilities.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative capability across the heart transplant pathway rather than a single product category. AI-enabled analytics can support candidate risk stratification, donor-recipient matching, imaging interpretation, hemodynamic trend analysis, donor-heart suitability assessment, and early detection of rejection or infection signals from electronic health records, laboratory data, wearables, biopsies, and molecular diagnostics outputs.

The strongest near-term value is decision support, not autonomous decision-making. Industry leaders must validate algorithms against registry-grade outcomes, reduce bias in underrepresented populations, preserve clinician oversight, and comply with medical-device, privacy, and cybersecurity regulations. Programs that integrate AI with transplant registry data, multidisciplinary review, and clinical governance are best positioned to improve organ utilization, patient surveillance, and long-term graft survival.

Key Regional Insights

Asia-Pacific is expanding through rising tertiary-care investment, larger heart failure populations, and growing transplant programs in China, India, Japan, South Korea, and Australia, although deceased-donor availability, public awareness, allocation governance, and reimbursement consistency vary widely. North America remains the highest-capacity region, led by the United States and Canada, supported by mature organ procurement networks, advanced mechanical circulatory support, established transplant-center accreditation, and robust outcomes reporting through national registries.

Latin America shows selective growth through established programs in Brazil and Mexico, but access remains uneven due to infrastructure gaps, donor conversion challenges, ICU capacity, and financing constraints. Europe benefits from national transplant authorities, public reimbursement, cross-border collaboration, and organ-sharing frameworks such as Eurotransplant, while the Middle East is investing in specialty cardiac centers, organ donation regulations, and advanced heart failure services. Africa remains an underpenetrated region where heart transplant activity is concentrated in a limited number of centers and constrained by workforce availability, critical-care infrastructure, donor-system maturity, and long-term immunosuppression access.

Key Group Insights

ASEAN markets are characterized by growing cardiovascular disease burden and improving tertiary hospitals, but heart transplant capacity remains concentrated in more advanced health systems with established deceased-donor programs, transplant governance, and post-operative intensive care. The GCC is accelerating investment in cardiac centers, transplant regulations, national donor registries, and advanced heart failure services, supported by health transformation strategies and rising demand for complex cardiovascular care.

The European Union benefits from harmonized regulatory standards, public funding, organ-sharing collaboration, and strong clinical research networks, making it a critical hub for transplant protocols, perfusion technologies, immunosuppression management, and post-transplant surveillance. BRICS countries represent large long-term demand pools, with China, India, and Brazil particularly important because of their expanding cardiovascular disease burden and increasing transplant-system capacity. G7 countries lead in research intensity, reimbursement depth, device adoption, registry transparency, and clinical guideline implementation, while NATO member markets overlap with many high-income systems that prioritize resilient medical supply chains, critical-care readiness, emergency preparedness, and cross-border clinical cooperation.

Key Country Insights

The United States leads global heart transplant activity by annual procedure volume, with OPTN data reporting more than 4,500 heart transplants performed in 2023, supported by a national allocation system, established organ procurement organizations, broad use of mechanical circulatory support, and detailed outcomes reporting. Canada maintains strong outcomes through regional transplant programs, public reimbursement, and coordinated donation systems, while Mexico and Brazil provide important Latin American capacity despite regional variation in access, donor availability, and specialized center distribution.

In Europe, the United Kingdom, Germany, France, Italy, and Spain operate mature transplant systems with strong public-sector coordination, established cardiac surgery expertise, and structured post-transplant follow-up, while Russia has growing specialized capacity but variable public transparency compared with Western European registries. In Asia-Pacific, China is scaling transplant services under evolving donation reforms and greater national oversight, India has high unmet need with expanding public and private programs, Japan emphasizes strict allocation rules and high-quality outcomes within a constrained donor environment, Australia has established national coordination and advanced retrieval logistics, and South Korea combines advanced hospital infrastructure with strong cardiovascular specialty care and growing transplant capability.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize organ utilization, outcomes transparency, and integrated post-transplant care. Investments in ex vivo perfusion, donor-heart assessment, rapid logistics, molecular rejection surveillance, infection management, immunosuppression optimization, medication adherence support, and remote monitoring can directly address the core constraints of donor scarcity and long-term graft preservation.

Commercial strategies should be tailored by market maturity. In established markets, differentiation should focus on evidence generation, AI-enabled workflow integration, value-based partnerships with transplant centers, and interoperability with registry and hospital data systems. In emerging markets, organizations should support workforce training, registry development, procurement-system strengthening, quality standards, and affordable financing models that expand safe access without compromising clinical quality.

Research Methodology

This executive summary is based on secondary research from verified public and institutional sources, including transplant registries, peer-reviewed clinical literature, health ministry publications, organ procurement organizations, international transplant societies, and regulatory agencies. Core reference frameworks include OPTN/SRTR, ISHLT registry reporting, Eurotransplant and national transplant authority data, WHO health-system indicators, and published heart failure epidemiology.

The analysis applies triangulation across procedure activity, clinical outcomes, policy changes, reimbursement structures, technology adoption, organ donation frameworks, and regional capacity indicators. Insights were screened for factual consistency, recency, and relevance to heart transplantation, advanced heart failure management, organ preservation, immunosuppression, diagnostics, digital health, and transplant-center operations.

Conclusion

The heart transplant landscape is advancing through the convergence of clinical innovation, organ-preservation technology, digital decision support, and stronger transplant-system governance. The central challenge remains unchanged: demand for suitable donor hearts exceeds supply, making every improvement in organ identification, preservation, allocation, implantation, and post-transplant management strategically important.

Organizations that align evidence-based technologies with transplant workflow realities will capture the strongest opportunities. The future competitive landscape will reward measurable improvements in donor-heart utilization, equitable access, survival outcomes, cost efficiency, regulatory readiness, and lifelong patient monitoring.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Heart Transplant Market, by Transplant Type

  • 7.1. Heterotopic Transplant
  • 7.2. Orthotopic Transplant
    • 7.2.1. Biatrial Technique
    • 7.2.2. Bicaval Technique
  • 7.3. Heart-Lung Transplant

8. Heart Transplant Market, by Graft Preservation

  • 8.1. Machine Perfusion
    • 8.1.1. Hypothermic Perfusion
    • 8.1.2. Normothermic Perfusion
  • 8.2. Static Cold Storage

9. Heart Transplant Market, by Product

  • 9.1. Donor-Based Transplantation
    • 9.1.1. Donation After Brain Death (DBD)
    • 9.1.2. Donation After Circulatory Death (DCD)
  • 9.2. Mechanical Circulatory Support
    • 9.2.1. Left Ventricular Assist Devices (LVAD)
    • 9.2.2. Right Ventricular Assist Devices (RVAD)
    • 9.2.3. Biventricular Assist Devices (BiVAD)
  • 9.3. Total Artificial Heart
  • 9.4. Organ Preservation & Transport Systems

10. Heart Transplant Market, by Patient Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Heart Transplant Market, by End User

  • 11.1. Hospitals
  • 11.2. Transplant Centers
  • 11.3. Specialty Cardiac Centers

12. Heart Transplant Market, by Indication

  • 12.1. Congenital Heart Disease
  • 12.2. Dilated Cardiomyopathy
  • 12.3. End Stage Heart Failure
  • 12.4. Ischemic Cardiomyopathy
  • 12.5. Valvular Heart Disease

13. Heart Transplant Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Heart Transplant Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Heart Transplant Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Becton, Dickinson and Company
  • 17.3. Berlin Heart GmbH
  • 17.4. BiVACOR, Inc.
  • 17.5. Boston Scientific Corporation
  • 17.6. Braile Biomedica Industria Comercio E Representacoes Ltda.
  • 17.7. BrioHealth Solutions, Inc.
  • 17.8. CARMAT SAS
  • 17.9. CH Biomedical, Inc.
  • 17.10. EUROSETS S.R.L.
  • 17.11. FineHeart
  • 17.12. Fresenius Medical Care AG
  • 17.13. Getinge AB
  • 17.14. Hemovent GmbH
  • 17.15. Jarvik Heart, Inc.
  • 17.16. Johnson & Johnson
  • 17.17. LivaNova PLC
  • 17.18. magAssist Co., Ltd.
  • 17.19. Medtronic plc
  • 17.20. MicroPort Scientific Corporation
  • 17.21. ReliantHeart, Inc.
  • 17.22. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
  • 17.23. Shenzhen Core Medical Technology Co., Ltd.
  • 17.24. Sun Medical Technology Research Corp.
  • 17.25. SynCardia Systems, LLC
  • 17.26. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART TRANSPLANT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HEART TRANSPLANT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HEART TRANSPLANT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HEART TRANSPLANT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HETEROTOPIC TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HETEROTOPIC TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HETEROTOPIC TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ORTHOTOPIC TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ORTHOTOPIC TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ORTHOTOPIC TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIATRIAL TECHNIQUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIATRIAL TECHNIQUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIATRIAL TECHNIQUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BICAVAL TECHNIQUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BICAVAL TECHNIQUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BICAVAL TECHNIQUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART-LUNG TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEART-LUNG TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEART-LUNG TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MACHINE PERFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MACHINE PERFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MACHINE PERFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HYPOTHERMIC PERFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HYPOTHERMIC PERFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HYPOTHERMIC PERFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NORMOTHERMIC PERFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NORMOTHERMIC PERFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NORMOTHERMIC PERFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STATIC COLD STORAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STATIC COLD STORAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STATIC COLD STORAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DONOR-BASED TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DONOR-BASED TRANSPLANTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DONOR-BASED TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DONATION AFTER BRAIN DEATH (DBD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DONATION AFTER BRAIN DEATH (DBD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DONATION AFTER BRAIN DEATH (DBD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DONATION AFTER CIRCULATORY DEATH (DCD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DONATION AFTER CIRCULATORY DEATH (DCD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DONATION AFTER CIRCULATORY DEATH (DCD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIVENTRICULAR ASSIST DEVICES (BIVAD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIVENTRICULAR ASSIST DEVICES (BIVAD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIVENTRICULAR ASSIST DEVICES (BIVAD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ORGAN PRESERVATION & TRANSPORT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ORGAN PRESERVATION & TRANSPORT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ORGAN PRESERVATION & TRANSPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CONGENITAL HEART DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONGENITAL HEART DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CONGENITAL HEART DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DILATED CARDIOMYOPATHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DILATED CARDIOMYOPATHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DILATED CARDIOMYOPATHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL END STAGE HEART FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL END STAGE HEART FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL END STAGE HEART FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ISCHEMIC CARDIOMYOPATHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ISCHEMIC CARDIOMYOPATHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ISCHEMIC CARDIOMYOPATHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GCC HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 177. GCC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 179. GCC HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 180. GCC HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 182. GCC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GCC HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. GCC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. G7 HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 210. G7 HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 211. G7 HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 212. G7 HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 213. G7 HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 214. G7 HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 215. G7 HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. G7 HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 218. NATO HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. NATO HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 221. NATO HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 222. NATO HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 223. NATO HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 224. NATO HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 225. NATO HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 226. NATO HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. NATO HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. NATO HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 244. CANADA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. MEXICO HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 256. MEXICO HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 263. BRAZIL HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. BRAZIL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 266. BRAZIL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 267. BRAZIL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 285. GERMANY HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. GERMANY HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 288. GERMANY HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 289. GERMANY HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 329. SPAIN HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. SPAIN HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. SPAIN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 332. SPAIN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 333. SPAIN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 334. SPAIN HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 335. SPAIN HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 337. SPAIN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 338. SPAIN HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 339. SPAIN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 340. CHINA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 341. CHINA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. CHINA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 343. CHINA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 344. CHINA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 345. CHINA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 346. CHINA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 349. CHINA HEART TRANSPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 350. CHINA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 351. INDIA HEART TRANSPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 352. INDIA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 353. INDIA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2018-2032 (USD MILLION)
  • TABLE 354. INDIA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 355. INDIA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2018-2032 (USD MILLION)
  • TABLE 356. INDIA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILL